Wegovy Dosing Guide: What the Titration Schedule Actually Means

The myth: a higher dose always means better results

The most persistent misconception about Wegovy is that more milligrams always means more weight lost. It is understandable. Trial results are often reported at the highest dose, so 2.4 mg or 7.2 mg becomes the number people fixate on. In practice, the relationship between dose and outcome is real but not linear for every individual. Some people achieve sustained, clinically meaningful weight loss at 1.0 mg or 1.7 mg and experience no additional benefit (but considerably more nausea) by pushing higher.

The titration schedule exists precisely because the right dose is the highest tolerated dose, not the highest available one. A prescriber looks at how well you are tolerating the current step, whether side effects have settled, and whether the clinical picture supports moving up. If 1.7 mg is working and 2.4 mg makes eating difficult or causes persistent vomiting, staying at 1.7 mg is the clinically sound call. That is not a failure of the treatment. It is the treatment working as designed.

The full Wegovy guide covers what semaglutide does in the body (briefly, it acts on GLP-1 receptors involved in appetite regulation and gastric emptying) but dosing decisions sit with your prescriber, informed by how your body responds at each step. If you want a broader overview of how the medicine works across its different uses, our semaglutide guide explains the underlying mechanism and what to expect before you begin. The NHS guidance on semaglutide covers this principle clearly, and it is worth reading before you start.

What each dose step is actually doing

At 0.25 mg, essentially nothing therapeutic is expected. That sounds blunt, but it is the honest framing: the first four weeks are an adjustment period. Your gut is meeting a new medicine, and the low dose gives it time to adapt. Nausea and indigestion at this stage are common; they almost always ease before the next step. Moving up before four weeks is up does not speed anything along and usually makes things worse.

From 0.5 mg onward, appetite suppression begins to be noticeable for most people. The 1.0 mg and 1.7 mg steps are where many patients report the clearest reduction in hunger and the first consistent changes in how much they can comfortably eat. By 2.4 mg (the previous standard maintenance dose) appetite suppression is typically pronounced, and the STEP 1 trial published in the New England Journal of Medicine found an average body-weight reduction of around 15% over 68 weeks at this dose among adults with obesity.

The 7.2 mg pathway, approved by the MHRA in early 2026, adds a further step for those who have reached 2.4 mg without reaching their clinical goals. Trials reported average weight loss of around 20.7% over 72 weeks at 7.2 mg, approaching results seen with the highest doses of tirzepatide. Whether that pathway is appropriate for you is a clinical question, and if you want to understand how each step is structured our Wegovy dosing page sets out the full titration schedule alongside the 7.2 mg data and approval context. Whether that pathway is appropriate for you is a clinical question; if you want to explore the evidence, our semaglutide dosing page sets out the 7.2 mg data and approval context alongside the full titration schedule.

Side effects by dose: what to expect and when

GI side effects (nausea, loose stools, constipation, reflux, burping) are most likely in the first days after a dose increase, then generally settle. They do not necessarily worsen with every step, though the first jump to each new level can bring a brief repeat of early symptoms. Most people find the pattern predictable once they have been through it once.

A few things are worth knowing and are easy to underestimate. Eating slowly, reducing portion sizes, avoiding very fatty meals and staying well hydrated all make a material difference to tolerance. Alcohol tends to worsen GI symptoms on semaglutide; that surprises people who were not told to expect it.

In January 2026 the MHRA updated its guidance on GLP-1 medicines to highlight acute pancreatitis as an infrequent but serious risk: severe stomach pain that reaches into the back, with or without vomiting, is a reason to stop the injection and get same-day medical help. This is not a reason to avoid semaglutide, it is a reason to know the sign. The Wegovy user guide covers injection technique and storage alongside this safety information in one place.

Women taking oral contraceptives should be aware that semaglutide's effect on gastric emptying can theoretically affect pill absorption in the first days after a dose step; current NHS guidance does not specify a requirement to add a barrier method for Wegovy in the way it does for tirzepatide, but it is worth raising with your prescriber at the relevant review. If you have questions about eligibility or how the consultation process works, the FAQs page has concise answers to most of them.

What prescribers look at before every dose change

At nume (at any legitimate UK online pharmacy) a prescriber reviews your case before every dose change and before every repeat supply. This is not paperwork. It is the point at which clinical judgement applies: are you tolerating the current dose? Has there been meaningful progress? Are there any new symptoms that warrant a pause or a conversation?

At nume, that review is done by a GPhC-registered Independent Prescriber, reading your actual responses the same day. Think of it as the clinical equivalent of a brief GP check-in before any prescription is written. That review happens before every repeat, no subscription that ticks over automatically, no dose sent without someone looking at the file. For a medicine titrated over months, that matters.

The cost of treatment is a practical question for many people, and the Wegovy cost page sets out what a private prescription typically covers and what to look for (or out for) when comparing providers. If you have done your reading and want to find out whether you are clinically suitable, you can start a free consultation at any point, no commitment required.